Skip to main content
Clinical Trials/DRKS00031072
DRKS00031072
Recruiting
Not Applicable

Retrospective evaluation of interventional treatment of peripheral slow-flow malformations using image-guided bleomycin electrotherapy. - BEST

MU München0 sites300 target enrollmentFebruary 16, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Q89
Sponsor
MU München
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
MU München

Eligibility Criteria

Inclusion Criteria

  • Patients with a diagnosis of combined slow\-flow peripheral vascular malformation (capillary\-venous malformation, CVM; capillary\-lymphatic malformation, CLM; lymphatic\-venous malformation, LVM; capillary\-lymphatic\-venous malformation, CLVM) and who have undergone imaging\-guided treatment by a Bleomycin electro\-sclerotherapy (BEST) in the form of one or more sessions in the period from 01\.01\.2020 to 30\.12\.2022

Exclusion Criteria

  • Patients with other vascular anomalies (high\-flow malformations) or vascular tumors
  • Patients who have received the above procedures with other image\-guided sclerotherapy/embolization techniques, e.g. B. Polidocanol sclerotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials